Abstract
Background: We depict the burden of heart failure (HF) in North America (NA) and Western Europe (WE), using a cyclical flow diagram of patients from diagnosis/hospitalization until treatment, stabilization and decompensation/death.Materials & methods: We obtained data on HF hospitalizations, prevalence, severity and treatment from national databases and primary/secondary research. Results: In 2020, we estimate 3.6 and 5.2 million HF hospitalizations, and 7.6 and 8.7 million diagnosed prevalent chronic HF (CHF) cases in NA and WE, respectively. All hospitalized HF and 86-88% of prevalent cases are drug-treated. The most widelyprescribed drugs for CHF in NA and WE are β-blockers and loop diuretics, respectively. Conclusion: The high burden of HF in NA and WE calls for greater efforts to prevent ischemic heart disease.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call